Last reviewed · How we verify
Migraine Relief
Migraine Relief is a Small molecule drug developed by Theranica. It is currently FDA-approved for Migraine prevention, Acute migraine treatment. Also known as: migraine treatment.
Migraine Relief is a wearable neuromodulation device that delivers electrical stimulation to the trigeminal nerve to prevent or treat migraine headaches.
Migraine Relief is a wearable neuromodulation device that delivers electrical stimulation to the trigeminal nerve to prevent or treat migraine headaches. Used for Migraine prevention, Acute migraine treatment.
At a glance
| Generic name | Migraine Relief |
|---|---|
| Also known as | migraine treatment |
| Sponsor | Theranica |
| Target | Trigeminal nerve |
| Modality | Small molecule |
| Therapeutic area | Neurology |
| Phase | FDA-approved |
Mechanism of action
The device uses transcutaneous electrical nerve stimulation (TENS) applied to the forehead to modulate trigeminal nerve activity, which is implicated in migraine pathophysiology. By delivering targeted electrical pulses, it aims to reduce migraine frequency, duration, and severity through non-pharmacological neuromodulation.
Approved indications
- Migraine prevention
- Acute migraine treatment
Common side effects
- Skin irritation at application site
- Mild discomfort during stimulation
- Headache
Key clinical trials
- A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PHASE3)
- Aerobic Exercise and Its Impact on Sensory, Musculoskeletal, and Psychosocial Aspects in Migraine (NA)
- Brief Interventions in Chronic Migraine (NA)
- Adolescent Lifestyle Medicine Headache Study (NA)
- Dietary Intervention for Migraine Relief (NA)
- China HeadAche DIsorders RegiStry
- App-based Breathing Program for Migraine Relief (NA)
- Safety of Nerivio in Pregnant Women With Migraine
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Migraine Relief CI brief — competitive landscape report
- Migraine Relief updates RSS · CI watch RSS
- Theranica portfolio CI
Frequently asked questions about Migraine Relief
What is Migraine Relief?
How does Migraine Relief work?
What is Migraine Relief used for?
Who makes Migraine Relief?
Is Migraine Relief also known as anything else?
What development phase is Migraine Relief in?
What are the side effects of Migraine Relief?
What does Migraine Relief target?
Related
- Target: All drugs targeting Trigeminal nerve
- Manufacturer: Theranica — full pipeline
- Therapeutic area: All drugs in Neurology
- Indication: Drugs for Migraine prevention
- Indication: Drugs for Acute migraine treatment
- Also known as: migraine treatment
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing